X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9392) 9392
Publication (603) 603
Book Chapter (155) 155
Dissertation (121) 121
Book Review (102) 102
Conference Proceeding (92) 92
Book / eBook (9) 9
Web Resource (6) 6
Data Set (5) 5
Magazine Article (3) 3
Government Document (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4575) 4575
drug interactions (3413) 3413
pharmacology & pharmacy (3413) 3413
drug-drug interactions (2883) 2883
index medicus (2848) 2848
animals (2665) 2665
male (2285) 2285
drug-drug interaction (2175) 2175
pharmacokinetics (1552) 1552
female (1490) 1490
rats (1092) 1092
receptors, drug - drug effects (1052) 1052
adult (970) 970
middle aged (855) 855
metabolism (828) 828
in-vitro (714) 714
aged (642) 642
pharmacology (592) 592
dose-response relationship, drug (589) 589
drug–drug interaction (582) 582
analysis (569) 569
inhibition (555) 555
mice (548) 548
drugs (512) 512
drug–drug interactions (496) 496
toxicology (493) 493
kinetics (482) 482
p-glycoprotein (475) 475
cytochrome p450 (433) 433
in vitro techniques (422) 422
biochemistry & molecular biology (421) 421
drug interaction (409) 409
cytochrome p-450 enzyme system - metabolism (405) 405
cytochrome p-450 (395) 395
young adult (375) 375
area under curve (370) 370
drug therapy, combination (360) 360
models, biological (357) 357
pharmacology/toxicology (344) 344
research (339) 339
chemistry, multidisciplinary (335) 335
enzymes (320) 320
receptors, drug - metabolism (314) 314
drug therapy (309) 309
human liver-microsomes (306) 306
liver (304) 304
rats, sprague-dawley (296) 296
adolescent (290) 290
prediction (290) 290
administration, oral (277) 277
time factors (270) 270
pharmacy (267) 267
metabolites (266) 266
therapy (264) 264
cytochrome p-450 cyp3a - metabolism (262) 262
polypharmacy (257) 257
chemistry, medicinal (256) 256
liver - metabolism (256) 256
cells, cultured (254) 254
cancer (251) 251
pharmaceutical preparations - metabolism (250) 250
cyp3a4 (247) 247
cross-over studies (245) 245
physiological aspects (245) 245
microsomes, liver - metabolism (240) 240
complications and side effects (239) 239
pharmacodynamics (235) 235
medicine & public health (231) 231
drug design (230) 230
aged, 80 and over (229) 229
protein binding (229) 229
oncology (228) 228
safety (223) 223
biomedicine (221) 221
enzyme inhibitors - pharmacology (216) 216
expression (214) 214
article (213) 213
microsomes, liver - drug effects (213) 213
internal medicine (211) 211
risk factors (210) 210
microsomes, liver - enzymology (206) 206
drug metabolism (203) 203
induction (202) 202
binding sites (200) 200
drug synergism (195) 195
warfarin (193) 193
structure-activity relationship (188) 188
cell line (187) 187
care and treatment (185) 185
dosage and administration (185) 185
rats, wistar (185) 185
risk (185) 185
healthy-volunteers (177) 177
absorption (175) 175
inhibitors (174) 174
health aspects (173) 173
prevalence (172) 172
hiv (171) 171
binding (170) 170
ketoconazole (170) 170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6313) 6313
Japanese (1800) 1800
Chinese (1414) 1414
German (63) 63
French (42) 42
Russian (27) 27
Spanish (27) 27
Slovenian (9) 9
Czech (7) 7
Korean (6) 6
Portuguese (6) 6
Polish (5) 5
Hungarian (2) 2
Italian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Journal Article
by Zhang, YP and Li, SP and Wang, YX and Deng, G and Cao, N and Wu, C and Ding, WZ and Wang, YW and Cheng, XM and Wang, CH
MOLECULES, ISSN 1420-3049, 04/2019, Volume 24, Issue 7, p. 1430
Harmine (HAR) is a beta-carboline alkaloid widely distributed in nature. It exhibits psychopharmacological effects of improving learning and memory. However,... 
SYSTEM | DEMENTIA | RAT | memantine | liquid chromatography-mass spectrometry | ALZHEIMERS-DISEASE | HARMALINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | harmine | MODEL | CHEMISTRY, MULTIDISCIPLINARY | BETA-CARBOLINE ALKALOIDS | MEMORY | pharmacokinetics | SPECIES-DIFFERENCES | MPTP | drug-drug interaction | Alzheimer's disease | Alzheimer’s disease
Journal Article
Journal Article
Journal Article
Journal Article